Inhibition of Leukocyte Entry into the Brain by the Selectin Blocker Fucoidin Decreases Interleukin-1 (IL-1) Levels but Increases IL-8 Levels in Cerebrospinal Fluid during Experimental Pneumococcal Meningitis in Rabbits
Open Access
- 1 June 2000
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 68 (6) , 3153-3157
- https://doi.org/10.1128/iai.68.6.3153-3157.2000
Abstract
The polysaccharide fucoidin is a selectin blocker that inhibits leukocyte recruitment into the cerebrospinal fluid (CSF) during experimental pneumococcal meningitis. In the present study, the effect of fucoidin treatment on the release of the proinflammatory cytokines tumor necrosis factor alpha (TNF-α), interleukin-1 (IL-1), and IL-8 into the CSF was investigated. Rabbits ( n = 7) were treated intravenously with 10 mg of fucoidin/kg of body weight every second hour starting 4 h after intracisternal inoculation of ∼10 6 CFU of Streptococcus pneumoniae type 3 (untreated control group, n = 7). CSF samples were obtained every second hour during a 16-h study period. Treatment with fucoidin caused a consistent and significant decrease in CSF IL-1 levels (in picograms per milliliter) between 12 and 16 h (0 versus 170, 0 versus 526, and 60 versus 1,467, respectively; P < 0.02). A less consistent decrease in CSF TNF-α levels was observed in the fucoidin-treated group, but with no significant difference between the two groups ( P > 0.05). In contrast, there was no attenuation in CSF IL-8 levels. Indeed, there was a significant increase in CSF IL-8 levels (in picograms per milliliter) in the fucoidin-treated group at 10 and 12 h (921 versus 574 and 1,397 versus 569, respectively; P < 0.09). In conclusion, our results suggest that blood-derived leukocytes mainly are responsible for the release of IL-1 and to some degree TNF-α into the CSF during pneumococcal meningitis, whereas IL-8 may be produced by local cells within the brain.Keywords
This publication has 31 references indexed in Scilit:
- Cytokines and Chemokines in Meningeal Inflammation: Biology and Clinical ImplicationsClinical Infectious Diseases, 1999
- Central nervous system TNFα-mRNA expression during rabbit experimental pneumococcal meningitisNeuroscience Letters, 1997
- Elimination of blood-derived macrophages inhibits the release of interleukin-1 and the entry of leukocytes into the cerebrospinal fluid in experimental pneumococcal meningitisJournal of Neuroimmunology, 1997
- Cytokine-induced meningitis is dramatically attenuated in mice deficient in endothelial selectins.Journal of Clinical Investigation, 1996
- The Limited Role of Pneumolysin in the Pathogenesis of Pneumococcal MeningitisThe Journal of Infectious Diseases, 1995
- Inhibition of leukocyte rolling with polysaccharide fucoidin prevents pleocytosis in experimental meningitis in the rabbit.Journal of Clinical Investigation, 1994
- Enhanced attenuation of meningeal inflammation and brain edema by concomitant administration of anti-CD18 monoclonal antibodies and dexamethasone in experimental Haemophilus meningitis.Journal of Clinical Investigation, 1991
- The role of cytokines in the generation of inflammation and tissue damage in experimental gram-positive meningitis.The Journal of Experimental Medicine, 1990
- Local production of tumor necrosis factor alpha, interleukin 1, and interleukin 6 in meningococcal meningitis. Relation to the inflammatory response.The Journal of Experimental Medicine, 1989
- Inhibition of Penicillin Transport from the Cerebrospinal Fluid after Intracisternal Inoculation of BacteriaJournal of Clinical Investigation, 1974